GLP-1 and Incretin Therapeutics
class007
Hormone-based drugs that activate incretin pathways to regulate glucose metabolism and appetite.
semaglutide|tirzepatide|retatrutide
glp1-receptor-activation|dual-incretin-signaling|triple-incretin-glucagon-signaling
fat-loss|metabolism|diabetes|appetite-suppression
GLP-1 and incretin metabolic therapies
Overview of semaglutide, tirzepatide, and retatrutide in metabolic and obesity treatment research.
published